Cargando…
Corticosteroid Plus Tocilizumab in COVID-19: When Two Is Better Than One
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American College of Chest Physicians. Published by Elsevier Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8097392/ https://www.ncbi.nlm.nih.gov/pubmed/33965134 http://dx.doi.org/10.1016/j.chest.2020.11.073 |
| _version_ | 1783688342906339328 |
|---|---|
| author | Kow, Chia Siang Hasan, Syed Shahzad |
| author_facet | Kow, Chia Siang Hasan, Syed Shahzad |
| author_sort | Kow, Chia Siang |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8097392 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | American College of Chest Physicians. Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-80973922021-05-05 Corticosteroid Plus Tocilizumab in COVID-19: When Two Is Better Than One Kow, Chia Siang Hasan, Syed Shahzad Chest Correspondence American College of Chest Physicians. Published by Elsevier Inc. 2021-05 2021-05-05 /pmc/articles/PMC8097392/ /pubmed/33965134 http://dx.doi.org/10.1016/j.chest.2020.11.073 Text en © 2021 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Correspondence Kow, Chia Siang Hasan, Syed Shahzad Corticosteroid Plus Tocilizumab in COVID-19: When Two Is Better Than One |
| title | Corticosteroid Plus Tocilizumab in COVID-19: When Two Is Better Than One |
| title_full | Corticosteroid Plus Tocilizumab in COVID-19: When Two Is Better Than One |
| title_fullStr | Corticosteroid Plus Tocilizumab in COVID-19: When Two Is Better Than One |
| title_full_unstemmed | Corticosteroid Plus Tocilizumab in COVID-19: When Two Is Better Than One |
| title_short | Corticosteroid Plus Tocilizumab in COVID-19: When Two Is Better Than One |
| title_sort | corticosteroid plus tocilizumab in covid-19: when two is better than one |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8097392/ https://www.ncbi.nlm.nih.gov/pubmed/33965134 http://dx.doi.org/10.1016/j.chest.2020.11.073 |
| work_keys_str_mv | AT kowchiasiang corticosteroidplustocilizumabincovid19whentwoisbetterthanone AT hasansyedshahzad corticosteroidplustocilizumabincovid19whentwoisbetterthanone |